General MedicationsINJECTIONGeneric
HALDOL
HALOPERIDOL DECANOATE
Standard Dose
EQ 50MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview HALDOL is listed in Drugs@FDA under application 018701 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient HALOPERIDOL DECANOATE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2025-10-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview HALDOL is listed in Drugs@FDA under application 018701 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HALOPERIDOL DECANOATE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/ML Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2025-10-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.